DK203582A - Fremgangsmaader og materialer til intravaginal kontraception - Google Patents

Fremgangsmaader og materialer til intravaginal kontraception Download PDF

Info

Publication number
DK203582A
DK203582A DK203582A DK203582A DK203582A DK 203582 A DK203582 A DK 203582A DK 203582 A DK203582 A DK 203582A DK 203582 A DK203582 A DK 203582A DK 203582 A DK203582 A DK 203582A
Authority
DK
Denmark
Prior art keywords
intravaginal
contraction
procedures
materials
intravaginal contraction
Prior art date
Application number
DK203582A
Other languages
English (en)
Inventor
B H Vickery
S Anik
R E Jones
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DK203582A publication Critical patent/DK203582A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fertilizers (AREA)
DK203582A 1981-05-07 1982-05-06 Fremgangsmaader og materialer til intravaginal kontraception DK203582A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/261,411 US4368186A (en) 1981-05-07 1981-05-07 Methods and compositions for intravaginal contraception

Publications (1)

Publication Number Publication Date
DK203582A true DK203582A (da) 1982-11-08

Family

ID=22993188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK203582A DK203582A (da) 1981-05-07 1982-05-06 Fremgangsmaader og materialer til intravaginal kontraception

Country Status (9)

Country Link
US (1) US4368186A (da)
EP (1) EP0065385A3 (da)
JP (1) JPS57192313A (da)
AU (1) AU8346082A (da)
DK (1) DK203582A (da)
FI (1) FI821600L (da)
IL (1) IL65699A (da)
NO (1) NO821496L (da)
ZA (1) ZA823136B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588581A (en) * 1984-11-16 1986-05-13 Basf Corporation Methods and compositions for intravaginal contraception
US4585647A (en) * 1984-11-19 1986-04-29 Basf Corporation Methods and compositions for intravaginal contraception
CA1331559C (en) 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
ATE64854T1 (de) * 1986-05-22 1991-07-15 Atlantic Pharma Prod Zusammensetzung mit hemmender wirkung auf zumindest ein einzelliges lebewesen und/oder virus, herstellungsverfahren und anwendungen dieser zusammensetzung.
FR2598916B1 (fr) * 1986-05-22 1988-09-09 Atlantic Pharma Prod Compose chimique fluore utilise dans une methode de contraception locale et composition contraceptive locale fluoree, notamment spermicide
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
IL86134A (en) * 1987-05-02 1993-06-10 Basf Ag N-substituted azoles, their manufacture and their use as pesticides and compositions containing them
US4904683A (en) * 1987-06-03 1990-02-27 Janssen Pharmaceutica N.V. Emulsifiable concentrates containing azoles
US5545615A (en) * 1987-09-18 1996-08-13 Zymogenetics, Inc. A method of inhibiting fertilization by alpha-1-antitrypsin or antithrombin III
FR2620698B1 (fr) * 1987-09-23 1990-08-10 Atlantic Pharma Prod Fluorure d'ammonium quaternaire et son application dans une substance inhibitrice ou destructrice d'etres vivants unicellulaires
EP0380084A3 (en) * 1989-01-27 1991-03-13 The Biomembrane Institute Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions
CA2040460C (en) * 1990-05-01 1997-06-10 Tacey X. Viegas Drug delivery with thermoreversible gels
US5593683A (en) * 1990-05-01 1997-01-14 Mdv Technologies, Inc. Method of making thermoreversible polyoxyalkylene gels
IT1250748B (it) * 1991-08-02 1995-04-21 Poli Ind Chimica Spa Formulazioni utili per il trattamento della secchezza vaginale
GR1001412B (el) * 1992-10-12 1993-11-30 Poli Ind Chimica Spa Συν?έσεις χρήσιμες δια την ?εραπευτική αγωγή της ξηρότητος του κόλπου.
US6245808B1 (en) 1998-11-05 2001-06-12 Parker Hughes Institute Oxy-vanadium (IV) complexes having spermicidal activity
US6051603A (en) * 1998-01-20 2000-04-18 Wayne Hughes Institute Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
US6432941B1 (en) * 1998-01-20 2002-08-13 Parker Hughes Institute Vanadium compounds for treating cancer
WO2004075854A2 (en) * 2003-02-26 2004-09-10 Program For Appropriate Technology In Health Microbicidal compositions and method of use
US20050037033A1 (en) * 2003-05-23 2005-02-17 Program For Appropriate Technology In Health Microbicidal compositions and methods and use
AU2004267383A1 (en) * 2003-08-14 2005-03-03 The Bio Balance Corporation Bacterial strains, compositions including same and probiotic use thereof
UA93354C2 (ru) 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
US8173593B2 (en) 2005-07-19 2012-05-08 The Population Council, Inc. Methods and compositions for emergency contraception using endothelin receptor antagonists
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
BRPI0904249B1 (pt) * 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
CN102711745A (zh) 2009-12-01 2012-10-03 谢普科斯生物技术有限公司 羟基酪醇及其衍生物用于预防hiv感染的局部用途
EP2546358A1 (en) 2011-07-15 2013-01-16 Laboratorios Del. Dr. Esteve, S.A. Methods and reagents for efficient control of HIV progression
EP2606897A1 (en) 2011-12-22 2013-06-26 Laboratorios Del. Dr. Esteve, S.A. Methods and compositions for the treatment of diseases caused by enveloped viruses
US10016361B2 (en) 2014-10-24 2018-07-10 Francoise Farron PH change in the vagina as a contraceptive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
US4277475A (en) * 1979-01-11 1981-07-07 Syntex (U.S.A.) Inc. Contraceptive methods employing 1-substituted imidazole derivatives

Also Published As

Publication number Publication date
IL65699A0 (en) 1982-08-31
FI821600L (fi) 1982-11-08
IL65699A (en) 1985-01-31
JPS57192313A (en) 1982-11-26
EP0065385A3 (en) 1983-06-15
FI821600A0 (fi) 1982-05-06
ZA823136B (en) 1983-12-28
AU8346082A (en) 1983-11-10
EP0065385A2 (en) 1982-11-24
NO821496L (no) 1982-11-08
US4368186A (en) 1983-01-11

Similar Documents

Publication Publication Date Title
DK203582A (da) Fremgangsmaader og materialer til intravaginal kontraception
DK493882A (da) Faeldningskiselsyre og fremgangsmaade til fremstilling deraf
DK160595C (da) Elektrofotografisk materiale og fremgangsmaade til fremstilling deraf
DK160659C (da) Elektrofotografisk materiale og fremgangsmaade til fremstilling deraf
DK304781A (da) Formdel og fremgansmaade til fremstolling heraf
JPS57112877A (en) Expansion and contraction device
DK99382A (da) Dichlorquinolinderivater og fremgangsmaade til fremstilling heraf
DK163818C (da) 4-fluor-2-halogen-5-nitrophenoler og en fremgangsmaade til fremstilling deraf
DK261782A (da) Overfladebehandlingsmetode og praeparat til cement
DK89083A (da) N-phosphonomethylglycinderivater og fremgangsmaade til fremstilling og brug deraf
DK130182A (da) Antagonister for argininvasopressin og fremgangsmaade til fremstilling heraf
DK446982A (da) Cyanosteroider og fremgangsmaade til deres fremstilling
DK276683A (da) Carbapenemer og fremgangsmaade til fremstilling deraf
DK123982A (da) Elektrofotografisk materiale og fremgangsmaade til fremstilling deraf
DK253083A (da) Amidiner og fremgangsmaade til fremstilling deraf
DK102182A (da) Vandfrit antitranspirationsmiddel og fremgangsmaade til fremstilling deraf
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK158682A (da) Fremgangsmaade til fremstilling af azopigmentpraeparater og disses anvendelse
DK124182A (da) Elektrofotografisk materiale og fremgangsmaade til fremstilling deraf
DK162126C (da) Elektrofotografisk materiale og fremgangsmaade til fremstilling deraf
DK160744C (da) Oxychloreringskatalysator-praekursor til oxychlorering og fremgangsmaade til fremstilling heraf
DK510885D0 (da) Polypeptider og fremgangsmaade til anvendelse deraf
DK271281A (da) Haardfeldt og fremgangsmaade til fremstilling deraf
DK343183A (da) Ketoquinoliner og fremgangsmaade til fremstilling deraf
DK372582A (da) Immunogent kompleks og fremgangsmaade til fremstilling deraf